Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0000950144-07-010587
Filing Date
2007-11-16
Accepted
2007-11-16 15:36:08
Documents
4

Document Format Files

Seq Description Document Type Size
1 CUMBERLAND PHARMACEUTICALS INC. g06286a7sv1za.htm S-1/A 2091379
2 EX-23.1 CONSENT OF KPMG LLP g06286a7exv23w1.htm EX-23.1 2808
3 GRAPHIC g06286a7g0628602.gif GRAPHIC 3768
4 GRAPHIC g06286a7g0628610.gif GRAPHIC 337
  Complete submission text file 0000950144-07-010587.txt   2101505
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: S-1/A | Act: 33 | File No.: 333-142535 | Film No.: 071253160
SIC: 2834 Pharmaceutical Preparations